Darrell Hulisz RPh, PharmD
Ambulatory Care Pharmacy, Geriatric Pharmacy, Pharmacotherapy, Psychiatric Pharmacy
Associate Professor, Department of Family Medicine & Community Health, Case Western Reserve University, School of Medicine, Doctor of Pharmacy, University Hospitals Medical Group
Join to View Full Profile
11100 Euclid AvenueBolwell Suite 1200Cleveland, OH 44106
Phone+1 216-844-3944
Darrell Hulisz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Darrell Hulisz is a clinical pharmacist based in Cleveland, OH, with subspecialties in ambulatory care pharmacy, geriatric pharmacy, pharmacotherapy, and psychiatric pharmacy. He obtained his PharmD in 1989 from the Medical University of South Carolina. His expertise includes metabolic syndrome, diabetes, geriatrics, pharmacology, and psychopharmacology. His recent publication is on the efficacy of GLP-RA plus an SGLT2 inhibitor for weight loss in obese and diabetic patients. His previous works cover a range of topics, including amyotrophic lateral sclerosis and alcohol-prescription drug interactions, and have been cited multiple times in other publications.
Education & Training
Medical University of South CarolinaPharmD, 1989
Publications & Presentations
PubMed
- 56 citationsAmyotrophic Lateral Sclerosis: Disease State OverviewDarrell Hulisz
The American Journal of Managed Care. 2018-08-01 - Treating skin and soft tissue infections.Geoffrey Mospan, Darrell Hulisz
JAAPA. 2017-01-01 - 9 citationsPharmacoepidemiology of potential alcohol–prescription drug interactions among primary care patients with alcohol-use disordersRichard L. Brown, Alan R. Dimond, Darrell Hulisz, Laura A. Saunders, James A. Bobula
Journal of the American Pharmacists Association. 2007-03-01
Journal Articles
- Does GLP-RA Plus an SGLT2 Inhibitor Yield Greater Weight Loss in Patients with Obesity and Diabetes than Monotherapy?Watkins C, Schilling Z, Kawalec K, Hulisz D, Current Cardiovascular Risk Reports, 8/8/2023
External Links
- LinkedInhttps://www.linkedin.com/in/dhulisz
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
